Venture capital (VC) is a vital form of funding for taking scientific ideas from lab to market, but for many academic scientists, negotiating with investors will be uncharted territory. Here, Dr Janita Good looks at how to make the most of current investor attentions...
"With the Covid-19 pandemic bringing in record levels of venture capital investment into life sciences and healthcare, there's no time like the present for those at the root of innovation to learn how to make the most of all the attention that VCs are giving to innovators within life sciences and healthcare." Dr Janita Good, Head of Life Sciences, Fieldfisher
